Company Filing History:
8 out of 262 
3 out of 8,373 
3 out of 1,373 
Years Active: 2022-2025
Title: Innovations by Qing Tan in Cardiac Support Technology
Introduction
Qing Tan is a prominent inventor based in Danvers, MA (US), known for her significant contributions to cardiac support technology. With a total of 8 patents, she has developed innovative solutions that enhance the treatment of serious cardiac conditions.
Latest Patents
One of her latest patents is a blood pump with the capability of electrocardiogram (EKG) monitoring, defibrillation, and pacing. This blood pump system includes a catheter, a pump housing, a rotor, a controller, and an electrode. The electrode senses EKG signals and transmits them to the controller, allowing for adjustments in the blood pump's operation based on the EKG signal and cardiac parameters derived from it. The controller can also determine the need for defibrillation or pacing and administer electrical shocks to the heart, making treatment more efficient and safer. Another notable patent involves systems and methods for determining cardiac performance. These systems utilize a mechanical circulatory support device to assess metrics of cardiac performance, calibrate, control, and deliver support for the heart. By introducing controlled perturbations in the vascular system, the device can determine critical heart parameters, ultimately leading to improved patient outcomes.
Career Highlights
Qing Tan has worked with notable organizations such as Abiomed, Inc. and the Massachusetts Institute of Technology. Her experience in these institutions has significantly influenced her innovative work in cardiac technology.
Collaborations
Qing has collaborated with talented individuals in her field, including Ahmad El Katerji and Noam Josephy. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Qing Tan's innovative work in cardiac support technology showcases her dedication to improving patient care through her inventions. Her patents reflect a commitment to enhancing the efficiency and safety of cardiac treatments.